中国医疗前沿2013,Issue(17) :60-60,61.DOI:10.3969/j.issn.1673-5552.2013.17.0044

川崎病丙种球蛋白治疗无效的高危因素分析

Gamma globulin treatment for Kawasaki disease risk factors invalid

康辉
中国医疗前沿2013,Issue(17) :60-60,61.DOI:10.3969/j.issn.1673-5552.2013.17.0044

川崎病丙种球蛋白治疗无效的高危因素分析

Gamma globulin treatment for Kawasaki disease risk factors invalid

康辉1
扫码查看

作者信息

  • 1. 330006 南昌,江西省儿童医院风湿免疫科
  • 折叠

摘要

目的:探讨分析对川崎病丙种球蛋白治疗无效的高危因素。方法回顾性分析2012年1月-2013年1月在我院行丙种球蛋白治疗川崎病400例患者的临床病例资料和实验室结果,根据治疗结果分为丙种球蛋白治疗有效组352例,丙种球蛋白治疗无效组48例。结果丙种球蛋白治疗无效组患者的血小板、血红蛋白、白蛋白明显低于治疗有效组,组间差异有统计学意义。结论川崎病丙种球蛋白治疗无效的高危因素主要包括:低血小板、贫血、低白蛋白血症等,临床应给予足够重视,减少对患儿冠状动脉的损伤。

Abstract

Objective To investigate the analysis of gamma globulin therapy Kawasaki disease risk factors. Methods A retrospective analysis of January 2012 January 2013 in our hospital gamma globulin treatment of Kawasaki disease in 400 patients of the clinical data and laboratory results, according to the treatment were divided into gamma globulin treatment effective group 352 cases, gamma globulin therapy group 48 cases. Results Gamma globulin therapy group of patients platelets was 301.7±126.1×109/L, the patient's hemoglobin was 104.2±16.9g/L, albumin 34.1±4.2g/L, significantly lower than the gamma globulin effective treatment group, the difference between the two groups, with statistically significant. Conclusion Kawasaki gamma globulin therapy in high-risk factors include: low platelets, anemia, hypoalbuminemia, etc., the clinical treatment of these children with Kawasaki disease should be given adequate attention, reducing the coronary arteries of children damage.

关键词

川崎病/丙种球蛋白/治疗/高危因素

Key words

Kawasaki disease/Gamma globulin/Treatment

引用本文复制引用

出版年

2013
中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
被引量2
参考文献量3
段落导航相关论文